Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by coyote13on Feb 10, 2017 12:52pm
461 Views
Post# 25829307

RE:RE:IPF

RE:RE:IPFHT: I am worried that you are  walking a little close to the edge of the ledge

Just to put your mind at ease, the PLI calendar ( from what I have read over the many 
years invested ) is intended to list dates for quarterly financial results/conference calls and conferences PLI scientists are attending. It is not intended to peg a date for the end of a clinical trial. No one does that to the best of my knowledge. And You should know that too.

PLI has been as  transparent  as one could expect  citing first half ( H1) and second half ( H2) of the year for expected completion of trials and related release of results together with any scientific body involvement. That information  has never appeared in any PLI calendar and I would be surprised if it ever did. Perhaps your TST managers cited an actual date for their news.

But why are you here? To get your cost of TST back , which by the way is what. That is rarely a successful investment strategy. Why didn't you sell at 14 cents if you thought PLI's prospects were so dismal?

But reach out to Fred and get all your questions answered so that you can make a more informed investment decision.

I know. Don't feed the trolls.

GLTA

Coyote13






Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse